Method for detecting triphenyl phosphite leached substance in medical instrument

By optimizing sample processing and chromatographic conditions in GC-MS detection, the complex and time-consuming problem of detecting triphenyl phosphate residues in medical devices in the prior art is solved, and fast, simple, high sensitivity and high accuracy detection is achieved , suitable for the production and market supervision and management of medical devices.

CN119044379APending Publication Date: 2024-11-29EPINTEK
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410426472.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-04-10
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

The existing methods for detecting triphenyl phosphate residues in medical devices are complex and time-consuming, with high operating requirements, insufficient sensitivity and specificity, making it difficult to meet the needs of rapid detection and on-site applications.

Method used

A gas chromatography mass spectrometer (GC-MS) combined with specific sample pretreatment and chromatography conditions is used to prepare a variety of standard solutions and sample solutions, and the detection steps are optimized to achieve high sensitivity and high accuracy detection.

Benefits of technology

It realizes rapid, simple, high sensitivity and high accuracy detection of triphenylphosphate residues in medical devices. It is suitable for production quality control and market supervision and management, providing low detection limit, simple pre-processing, rapid analysis and high Repeatable test results.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119044379A_ABST
    Figure CN119044379A_ABST
Patent Text Reader

Abstract

The invention discloses a method for detecting a triphenyl phosphite leached substance in a medical instrument. The method comprises the following steps: preparing a repetitive solution: precisely transferring 600mu L of a TPP standard stock solution with the concentration of 10.558 mu g / mL, putting the TPP standard stock solution into a 10mL volumetric flask, adding ethyl acetate to dilute the TPP standard stock solution to the scale, uniformly shaking the TPP standard stock solution, and preparing six parts in parallel to obtain the repetitive solution with the concentration of 0.633 mu g / mL; the method is not only suitable for production quality control of the medical apparatus, but also can be used for market supervision and management of the medical apparatus, and an effective technical means is provided for guaranteeing the safety of the medical apparatus. The invention provides a detection method based on a gas-liquid chromatography-mass spectrometry (GC-MS) technology, and high-sensitivity and high-accuracy detection of the triphenyl phosphite leached substance in the medical instrument is realized through specific sample pretreatment and optimized chromatographic conditions. And detailed methodological verification is carried out. The method has the characteristics of low detection limit, simplicity and convenience in pretreatment, high analysis speed, high repeatability, good accuracy and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of detection of triphenyl phosphite leachable matter, and specifically relates to a method for detecting triphenyl phosphite leachable matter in medical devices. Background Art

[0002] With the rapid development of the medical device industry, concerns about the safety of medical devices are also increasing. Triphenyl phosphite (TPP), as a commonly used plasticizer, is widely used in a variety of medical device materials to improve their physical and chemical properties. However, TPP residues may pose a potential risk to human health, especially when these devices are used for long-term implantation or direct contact with blood and other body fluids. Therefore, accurate and effective detection of TPP residues in medical devices has become an important part of ensuring the safety of medical devices.

[0003] In the prior art, methods for detecting TPP residues in medical devices mainly include gas chromatography, liquid chromatography, etc. Although these methods can provide accurate test results under specific conditions, they usually require complex sample pretreatment processes, are time-consuming, and have high technical requirements for operators, limiting their widespread use in rapid detection and on-site detection applications. In addition, the sensitivity and specificity of some methods still need to be improved to meet the increasingly stringent medical device safety standards.

[0004] Therefore, there is an urgent need for a new detection method that can provide a faster, simpler, more sensitive and specific TPP residue detection to meet the actual needs of medical device production and supervision. Summary of the invention

[0005] The object of the present invention is to provide a method for detecting triphenyl phosphite leachable matter in medical devices in order to solve the above-mentioned problems.

[0006] The technical solution adopted by the present invention is as follows: a method for detecting triphenyl phosphite leachable matter in medical devices, the detection method comprising the following steps:

[0007] S1: Instrument preparation: gas chromatography-mass spectrometry (GC-MS);

[0008] S2: Prepare the test solution: Take one sample each, add 40 mL of ethyl acetate at a ratio of 3 cm2 / mL, and extract for 24 h at 37°C ± 1°C to simulate the clinical use temperature. Separate the sample from the liquid, cool the solution to room temperature, and prepare 2 portions of each extraction solvent in parallel as the sample test solution;

[0009] S3: Prepare blank sample solution: Take the same volume of ethyl acetate from the same batch, without adding sample, and refer to the test solution treatment method to obtain a blank sample solution;

[0010] S4: Preparation of TPP standard stock solution A: Accurately weigh 18.03 mg (97.6%) of TPP, and add toluene to prepare a TPP standard stock solution with a concentration of 1.7597 mg / mL;

[0011] S5: Preparation of TPP standard stock solution B: Accurately pipette 60 μL of TPP standard stock solution A into a 10 mL volumetric flask, dilute to scale with ethyl acetate, and shake well to obtain a 10.558 μg / mL repeatability solution;

[0012] S6: Prepare linear solutions: accurately pipette appropriate amounts of TPP standard stock solutions, dilute with ethyl acetate, and prepare 5 concentration gradient standard curve solutions, which are recorded as STD1, STD2, STD3, STD4 and STD5;

[0013] S7: Prepare detection limit solution: prepare 52.8 ng / mL TPP standard solution. The signal-to-noise ratio of the response value of the solution shall not be less than 3:1.

[0014] S8: Prepare the quantitative limit solution: prepare a 158.4 ng / mL TPP solution. The signal-to-noise ratio of the response value of the solution should not be less than 10:1. The concentration corresponding to the solution is used as the quantitative limit;

[0015] S9: Prepare a repeatability solution: accurately pipette 600 μL of 10.558 μg / mL TPP standard stock solution into a 10 mL volumetric flask, dilute to scale with ethyl acetate, shake well, and prepare six replicates in parallel to obtain a 0.633 μg / mL repeatability solution;

[0016] S10: Accuracy solution: Prepare three solutions with different concentration levels: low, medium, and high as accuracy solutions;

[0017] S11: GC-MS analysis is used to determine the content of triphenyl phosphite leachable matter in the sample, and the data results obtained from the analysis are recorded and saved, and then the detection process of triphenyl phosphite leachable matter can be terminated.

[0018] In a preferred embodiment, in step S1, the starting temperature is 80°C, maintained for 0 min, heated to 220°C at a rate of 20°C / min, maintained for 1 min, heated to 300°C at a rate of 20°C / min, maintained for 1 min.

[0019] In a preferred embodiment, in step S1, the instrument is prepared by adjusting various parameters to a working state: the carrier gas is helium; the chromatographic column is HP-5MSUI, 30m×250μm×0.25μm chromatographic column.

[0020] In a preferred embodiment, in step S1, the injection port temperature is set to 280°C; the injection volume is set to 1 μL: the split mode is set to non-split mass spectrometry transmission; the line temperature is set to 300°C; the ion source is set to EI; the ion source temperature is set to 230°C; and the quadrupole temperature is set to 150°C.

[0021] In a preferred embodiment, in step S2, the surface area of ​​a single sample is 120.99 square centimeters.

[0022] In a preferred embodiment, in step S7, the concentration corresponding to the quantitative limit solution is used as the detection limit.

[0023] In a preferred embodiment, in step S10, 1.0 mL of TPP standard stock solution is accurately pipetted and added into 9.0 mL of ethyl acetate, and then the solution is extracted at 37°C±1°C for 24 hours and then cooled to obtain accuracy solution 3, and three portions are prepared in parallel.

[0024] In a preferred embodiment, in step S10, 0.6 mL of TPP standard stock solution is precisely pipetted and added into 9.4 mL of ethyl acetate, and then the solution is extracted at 37°C±1°C for 24 hours and then cooled to obtain accuracy solution 2, and three portions are prepared in parallel.

[0025] In a preferred embodiment, in step S10, 0.4 mL of TPP standard stock solution is accurately pipetted and added into 9.6 mL of ethyl acetate, and then the solution is extracted at 37°C±1°C for 24 hours and then cooled to obtain accuracy solution 1, and three replicates are prepared in parallel.

[0026] In a preferred embodiment, in step S11, the quantitative and qualitative ions of triphenyl phosphite are: 77, 153, 217.

[0027] In summary, due to the adoption of the above technical solution, the beneficial effects of the present invention are:

[0028] The present invention is not only applicable to the production quality control of medical devices, but also can be used for the market supervision and management of medical devices, providing an effective technical means to ensure the safety of medical devices. The invention provides a detection method based on gas-liquid chromatography-mass spectrometry (GC-MS), which achieves high sensitivity and high accuracy detection of triphenyl phosphite leachables in medical devices through specific sample pretreatment and optimized chromatographic conditions. A detailed methodological verification is also carried out. The method has a low detection limit, simple pretreatment, fast analysis speed, high repeatability, good accuracy and the like. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1 It is the spectrum of TPP standard solution (STD4) of the present invention;

[0030] Figure 2 It is the toluene blank solution spectrum in the present invention;

[0031] Figure 3 This is the spectrum of the blank solution of ethyl acetate in the present invention;

[0032] Figure 4 It is the sample blank solution spectrum in the present invention;

[0033] Figure 5 It is the spectrum of the test solution in the present invention;

[0034] Figure 6 This is a graph showing the results of the TPP linear test in the present invention. DETAILED DESCRIPTION

[0036] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.

[0037] Reference Figure 1-6 ,

[0038] A method for detecting triphenyl phosphite leachable matter in medical devices, the detection method comprising the following steps:

[0039] The following steps are involved:

[0040] 1) Instrument preparation: Gas chromatography-mass spectrometry (GC-MS)

[0041] 2) Test solution: Take one sample each (the surface area of ​​a single sample is 120.99 cm2), add 40 mL of ethyl acetate at a ratio of 3 cm2 / mL, and extract for 24 h at 37°C±1°C to simulate the clinical use temperature. Separate the sample from the liquid and cool the solution to room temperature. Prepare 2 portions of each extraction solvent in parallel as the sample test solution.

[0042] 3) Blank sample solution: Take the same volume of ethyl acetate from the same batch, without adding sample and refer to the test solution treatment method to obtain a blank sample solution.

[0043] 4) TPP standard stock solution A: Accurately weigh 18.03 mg (97.6%) of TPP and add toluene to prepare a TPP standard stock solution with a concentration of 1.7597 mg / mL.

[0044] 5) TPP standard stock solution B: Accurately pipette 60 μL of TPP standard stock solution A into a 10 mL volumetric flask, dilute to the mark with ethyl acetate, and shake well to obtain a 10.558 μg / mL repeatability solution.

[0045] 6) Linear solution: Accurately pipette an appropriate amount of TPP standard stock solution, dilute it with ethyl acetate, and prepare 5 standard curve solutions with concentration gradients, which are recorded as STD1, STD2, STD3, STD4 and STD5.

[0046] 7) Detection limit solution: Prepare a 52.8 ng / mL TPP standard solution. The response value signal-to-noise ratio of this solution should not be less than 3:1. The concentration corresponding to this solution is used as the detection limit.

[0047] 8) Quantitation limit solution: Prepare a 158.4 ng / mL TPP solution. The signal-to-noise ratio of the response value of this solution must not be less than 10:1. The concentration corresponding to this solution is used as the quantitation limit.

[0048] 9) Repeatability solution: Accurately pipette 600 μL of 10.558 μg / mL TPP standard stock solution into a 10 mL volumetric flask, dilute to the mark with ethyl acetate, shake well, and prepare six replicates in parallel to obtain a 0.633 μg / mL repeatability solution.

[0049] 10) Accuracy solution: Prepare three solutions with different concentration levels: low, medium, and high as accuracy solutions.

[0050] (1) Accurately pipette 0.4 mL of TPP standard stock solution and add it to 9.6 mL of ethyl acetate. Extract at 37°C ± 1°C for 24 h and then cool to obtain accuracy solution 1. Prepare three replicates in parallel.

[0051] (2) Accurately pipette 0.6 mL of TPP standard stock solution and add it to 9.4 mL of ethyl acetate. Extract at 37°C ± 1°C for 24 h and then cool to obtain accuracy solution 2. Prepare three replicates in parallel.

[0052] (3) Accurately pipette 1.0 mL of TPP standard stock solution and add it to 9.0 mL of ethyl acetate. Extract at 37°C ± 1°C for 24 h and then cool to obtain accuracy solution 3. Prepare three replicates in parallel.

[0053] 11) GC-MS was used to determine the content of TPP in the sample.

[0054] In step 1), the instrument is ready to adjust various parameters to the working state: the carrier gas is helium; the chromatographic column is HP-5MS UI, 30m×250μm×0.25μm chromatographic column;

[0055] In step 1), the starting temperature is 80°C, maintained for 0 min, heated to 220°C at a rate of 20°C / min, maintained for 1 min, heated to 300°C at a rate of 20°C / min, maintained for 1 min.

[0056] In step 1), injection port temperature: 280°C; injection volume: 1 μL; split mode: splitless; mass spectrometer transmission line temperature: 300°C; ion source: EI; ion source temperature: 230°C; quadrupole temperature: 150°C.

[0057] Quantitative and qualitative ions of TPP 77, 153, 217.

[0058] The leaching material of the disposable dialysis blood circuit tube is an ethyl acetate extract.

[0059] The present invention belongs to the detection of known leachable substances in medical devices. The present invention adopts a gas chromatography-mass spectrometry (GC-MS) to determine a method for determining triphenyl phosphite (TPP) in medical device leachable substances, and performs detailed methodological verification. The method has a low detection limit, simple pretreatment, fast analysis speed, high repeatability, good accuracy, etc. The method provides a feasible method for detecting TPP in medical device leachable substances.

[0060] Disposable hemodialysis circuit catheter embodiment 1:

[0061] Instruments and reagents

[0062] Gas chromatography-mass spectrometry (Agilent Technologies (China) Co., Ltd. 8890+5977B+7697A with EI ion source), electronic balance (accuracy 0.0001g, Mettler Toledo, Switzerland), triphenyl phosphite (TPP) (100 mg / bottle, Tanmo Quality Inspection Standard Material Center), ethyl acetate (500 mL / bottle, Tianjin Komiou Chemical Reagent Co., Ltd.)

[0063] Instrument conditions

[0064] The instrument parameter settings of TPP gas chromatograph are shown in Table 1.

[0065] Table 1 GC-MS instrument conditions

[0066]

[0067] 1. Solution preparation

[0068] 1) Test solution: Take one sample each (the surface area of ​​a single sample is 120.99 cm2), add 40 mL of ethyl acetate at a ratio of 3 cm2 / mL, and extract for 24 h at 37°C ± 1°C to simulate the clinical use temperature. Separate the sample from the liquid and cool the solution to room temperature. Prepare 2 portions of each extraction solvent in parallel as the sample test solution.

[0069] 2) Blank sample solution: Take the same volume of ethyl acetate from the same batch, without adding sample and refer to the test solution treatment method to obtain a blank sample solution.

[0070] 3) TPP standard stock solution A: Accurately weigh 18.03 mg (97.6%) of TPP and add toluene to prepare a TPP standard stock solution with a concentration of 1.7597 mg / mL.

[0071] 4) TPP standard stock solution B: Accurately pipette 60 μL of TPP standard stock solution A into a 10 mL volumetric flask, dilute to the mark with ethyl acetate, and shake well to obtain a 10.558 μg / mL repeatability solution.

[0072] 5) Linear solution: Accurately pipette an appropriate amount of TPP standard stock solution, dilute it with ethyl acetate, and prepare 5 standard curve solutions with concentration gradients, which are recorded as STD1, STD2, STD3, STD4 and STD5.

[0073] 6) Detection limit solution: Prepare a 52.8 ng / mL TPP standard solution. The response value signal-to-noise ratio of this solution should not be less than 3:1. The concentration corresponding to this solution is used as the detection limit.

[0074] 7) Quantitation limit solution: Prepare a 158.4 ng / mL TPP solution. The response signal-to-noise ratio of this solution must not be less than 10:1. The concentration corresponding to this solution is used as the quantitation limit.

[0075] 8) Repeatability solution: Accurately pipette 600 μL of 10.558 μg / mL TPP standard stock solution into a 10 mL volumetric flask, dilute to the mark with ethyl acetate, shake well, and prepare six replicates in parallel to obtain a 0.633 μg / mL repeatability solution.

[0076] 9) Accuracy solution: Prepare three solutions with different concentration levels: low, medium, and high as accuracy solutions. (1) Accurately pipette 0.4 mL of TPP standard stock solution into 9.6 mL of ethyl acetate, extract at 37°C ± 1°C for 24 h, and then cool to obtain accuracy solution 1. Prepare three replicates in parallel.

[0077] (2) Accurately pipette 0.6 mL of TPP standard stock solution and add 9.4 mL of ethyl acetate. Extract at 37°C ± 1°C for 24 h and then cool to obtain accuracy solution 2. Prepare three replicates in parallel.

[0078] (3) Accurately pipette 1.0 mL of TPP standard stock solution and add it to 9.0 mL of ethyl acetate. Extract at 37°C ± 1°C for 24 h and then cool to obtain accuracy solution 3. Prepare three replicates in parallel.

[0079] 2. Method Validation

[0080] 4.1. Exclusivity

[0081] The reagent blank solution, blank sample solution, test solution and TPP standard solution (1.059 μg / mL) were tested on the machine respectively, and the chromatograms were recorded. Figure 1 to Figure 6 It can be seen that there is no interfering peak near the target peak (TPP) in the TPP standard solution, toluene blank solution, ethyl acetate blank solution, ethyl acetate sample blank and test solution. The specific test results are shown in Table 2. From the above results, it can be seen that this method has good specificity.

[0082] Table 2 TPP test specificity results

[0083] name TPP standard solution Toluene blank solution Ethyl acetate blank solution Sample blank solution Test solution Interference peak none none none none none Peak area 2266645 Not detected Not detected Not detected 502022

[0084] 4.2. Linear

[0085] The blank solution and the linear solution were tested. The results showed that the correlation coefficient of the linear equation of the target peak was 0.996. The specific results are shown in Table 3. From the above results, it can be seen that this method has good linearity.

[0086] Table 3 TPP linearity test results

[0087]

[0088] 4.3 Limit of detection and limit of quantification

[0089] The detection limit and quantification limit solutions of TPP were tested on the machine according to the conditions in Table 1. The solution corresponding to the signal-to-noise ratio of the response value of TPP should not be lower than 3:1 was the detection limit; the solution corresponding to the signal-to-noise ratio of the response value should not be lower than 10:1 was the quantification limit; the specific results are shown in Table 4.

[0090] Table 4 Results of detection limit and quantification limit of TPP

[0091]

[0092] 4.4. Repeatability

[0093] The repeatability solution was tested on the machine, and the test results are shown in Table 5. According to the 9101 Validation Guidelines for Analytical Methods in the 2020 Edition of the Chinese Pharmacopoeia, the RSD should be less than 8%. Table 5 shows that this method has good repeatability.

[0094] Table 5 TPP repeatability test results

[0095]

[0096] 4.5. Accuracy

[0097] The accuracy solution was tested on the machine, and the test results are shown in Table 6. According to the 9101 Analytical Method Verification Guidelines of the 2020 Edition of the Chinese Pharmacopoeia, the acceptable range of TPP recovery in accuracy solution 1 and accuracy solution 2 is 75%-120%, and the acceptable range of TPP recovery in accuracy solution 2 is 80%-115%. As shown in Table 6, this method has good accuracy.

[0098] Table 6 TPP accuracy test results

[0099]

[0100] 5. TPP content test results

[0101] The GC-MS test was used and the TPP test results are shown in Table 7.

[0102] Table 7 TPP content test results

[0103]

[0104] The present invention is not only applicable to the production quality control of medical devices, but also can be used for the market supervision and management of medical devices, providing an effective technical means to ensure the safety of medical devices. The invention provides a detection method based on gas-liquid chromatography-mass spectrometry (GC-MS), which achieves high sensitivity and high accuracy detection of triphenyl phosphite leachables in medical devices through specific sample pretreatment and optimized chromatographic conditions. A detailed methodological verification is also carried out. The method has a low detection limit, simple pretreatment, fast analysis speed, high repeatability, good accuracy and the like.

[0105] It should be noted that, in this article, relational terms such as first and second, etc. are only used to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply any such actual relationship or order between these entities or operations. Moreover, the terms "include", "comprise" or any other variants thereof are intended to cover non-exclusive inclusion, so that a process, method, article or device including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, method, article or device. In the absence of further restrictions, the elements defined by the sentence "comprise a ..." do not exclude the existence of other identical elements in the process, method, article or device including the elements.

[0106] The above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit the same. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that the technical solutions described in the aforementioned embodiments may still be modified, or some of the technical features may be replaced by equivalents. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.

Claims

1. A method for detecting triphenyl phosphite leachable matter in medical devices, characterized in that: The detection method comprises the following steps: S1: Prepare the instrument: gas chromatography-mass spectrometry (GC-MS); S2: Prepare the test solution: Take one sample each, add 40 mL of ethyl acetate at a ratio of 3 cm2 / mL, and extract for 24 h at 37°C ± 1°C to simulate the clinical use temperature. Separate the sample from the liquid, cool the solution to room temperature, and prepare 2 portions of each extraction solvent in parallel as the sample test solution; S3: Prepare blank sample solution: Take the same volume of ethyl acetate from the same batch, without adding sample, and refer to the test solution treatment method to obtain a blank sample solution; S4: Preparation of TPP standard stock solution A: Accurately weigh 18.03 mg (97.6%) of TPP, and add toluene to prepare a TPP standard stock solution with a concentration of 1.7597 mg / mL; S5: Preparation of TPP standard stock solution B: Accurately pipette 60 μL of TPP standard stock solution A into a 10 mL volumetric flask, dilute to scale with ethyl acetate, and shake well to obtain a 10.558 μg / mL repeatability solution; S6: Prepare linear solutions: accurately pipette appropriate amounts of TPP standard stock solutions, dilute with ethyl acetate, and prepare 5 concentration gradient standard curve solutions, which are recorded as STD1, STD2, STD3, STD4 and STD5; S7: Prepare detection limit solution: prepare 52.8 ng / mL TPP standard solution. The signal-to-noise ratio of the response value of the solution shall not be less than 3:

1. S8: Prepare the quantitative limit solution: prepare a 158.4 ng / mL TPP solution. The signal-to-noise ratio of the response value of the solution must not be less than 10:

1. The concentration corresponding to the solution is used as the quantitative limit. S9: Prepare a repeatability solution: accurately pipette 600 μL of 10.558 μg / mL TPP standard stock solution into a 10 mL volumetric flask, dilute to scale with ethyl acetate, shake well, and prepare six replicates in parallel to obtain a 0.633 μg / mL repeatability solution; S10: Accuracy solution: Prepare three solutions with different concentration levels: low, medium, and high as accuracy solutions; S11: GC-MS analysis is used to determine the content of triphenyl phosphite leachable matter in the sample, and the data results obtained from the analysis are recorded and saved, and then the detection process of triphenyl phosphite leachable matter can be terminated.

2. A method for detecting triphenyl phosphite leachable matter in a medical device according to claim 1, characterized in that: In the step S1, the starting temperature is 80°C, maintained for 0 min, heated to 220°C at a rate of 20°C / min, maintained for 1 min, heated to 300°C at a rate of 20°C / min, maintained for 1 min.

3. A method for detecting triphenyl phosphite leachable matter in a medical device according to claim 1, characterized in that: In step S1, the instrument is prepared by adjusting various parameters to a working state: the carrier gas is helium; the chromatographic column is HP-5MSUI, 30m×250μm×0.25μm chromatographic column.

4. A method for detecting triphenyl phosphite leachable matter in a medical device as claimed in claim 1, characterized in that: In step S1, the injection port temperature is set to 280°C; the injection volume is set to 1 μL; the split mode is set to splitless mass spectrometry transmission; the line temperature is set to 300°C; the ion source is set to EI; the ion source temperature is set to 230°C; and the quadrupole temperature is set to 150°C.

5. The method for detecting triphenyl phosphite leachable matter in a medical device according to claim 1, characterized in that: In step S2, the surface area of ​​a single sample is 120.99 square centimeters.

6. A method for detecting triphenyl phosphite leachable matter in a medical device according to claim 1, characterized in that: In step S7, the concentration corresponding to the quantitative limit solution is used as the detection limit.

7. A method for detecting triphenyl phosphite leachable matter in a medical device according to claim 1, characterized in that: In the step S10, 1.0 mL of TPP standard stock solution is accurately pipetted and added to 9.0 mL of ethyl acetate, and the solution is extracted at 37° C.±1° C. for 24 hours and then cooled to obtain accuracy solution 3, which is prepared in triplicate.

8. A method for detecting triphenyl phosphite leachable matter in a medical device as claimed in claim 1, characterized in that: In the step S10, 0.6 mL of TPP standard stock solution is precisely pipetted and added to 9.4 mL of ethyl acetate, and the solution is extracted at 37° C.±1° C. for 24 hours and then cooled to obtain accuracy solution 2, which is prepared in triplicate.

9. A method for detecting triphenyl phosphite leachable matter in a medical device according to claim 1, characterized in that: In the step S10, 0.4 mL of TPP standard stock solution is precisely pipetted and added to 9.6 mL of ethyl acetate, and the solution is extracted at 37° C.±1° C. for 24 hours and then cooled to obtain accuracy solution 1, which is prepared in triplicate.

10. A method for detecting triphenyl phosphite leachable matter in a medical device according to claim 1, characterized in that: In step S11, the quantitative and qualitative ions of triphenyl phosphite are: 77, 153, 217.

Citation Information

Cited By

  • Method and system for rapidly detecting purity constant value of triphenyl phosphate

    CN121577812A